Nexgel (NXGL) Net Cash Flow Growth (3y) (2022 - 2025)
Nexgel (NXGL) Net Cash Flow Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.19 Bn | 120.97 Bn | 1.96 Bn | -16.59% |
| 2 | Becton Dickinson | 44.76 Bn | 43.95 Bn | 2.15 Bn | -55.30% |
| 3 | Alcon | 32.93 Bn | 31.28 Bn | 1.53 Bn | 39.87% |
| 4 | Medline | 32.80 Bn | 30.56 Bn | 1.84 Bn | - |
| 5 | Resmed | 29.51 Bn | 27.85 Bn | 890.98 Mn | 126.35% |
| 6 | West Pharmaceutical Services | 23.59 Bn | 23.15 Bn | 329.20 Mn | 2.16% |
| 7 | Solventum | 14.01 Bn | 13.45 Bn | 1.10 Bn | -159.90% |
| 8 | Cooper Companies | 13.77 Bn | 13.63 Bn | 735.40 Mn | 78.59% |
| 9 | Align Technology | 12.03 Bn | 10.97 Bn | 736.59 Mn | 36.49% |
| 10 | Nexgel | 3.43 Mn | 1.63 Mn | 819,000.00 | -34.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -34.88% |
| Sep 30, 2025 | 33.49% |
| Jun 30, 2025 | 58.15% |
| Mar 31, 2025 | 39.88% |
| Dec 31, 2024 | -60.45% |
| Sep 30, 2024 | -26.23% |
| Jun 30, 2024 | -25.19% |
| Mar 31, 2024 | -31.44% |
| Dec 31, 2023 | -65.44% |
| Sep 30, 2023 | -77.50% |
| Jun 30, 2023 | 506.76% |
| Mar 31, 2023 | -97.11% |
| Dec 31, 2022 | -57.20% |
| Sep 30, 2022 | -212.58% |